Recombinant PCSK9 (Evolocumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target
- PCSK9 (Evolocumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
- Host
-
Mammalian Cells
- Expression System
- Mammalian cells
- Clonality
- Monoclonal
- Application
- ELISA
- Purpose
- Evolocumab Biosimilar - Anti-PCSK9 mAb
- Characteristics
- Antibody Type: IgG2-lambda
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG2 lambda
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- PCSK9 (Evolocumab Biosimilar)
- Target Type
- Biosimilar
- Background
-
AMG 145,Anti-PCSK9
Evolocumab is a human IgG2 monoclonal antibody that binds to and prevents the binding of the proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that binds to LDL receptors for degradation, thus reducing the liver’s activity of removal of LDL-cholesterol (LDL-C) from the blood. It is used in the treatment of hyperlipidemia. - CAS-No
- 1256937-27-5
-
You are here:
